Company / Net Debt per Share
Harmony Biosciences Holdings, Inc. Net Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$10.30
FY2025
5-year range
-$10.30 / -$0.78
FY2021-FY2025
Trend
-113.7%
vs FY2024
Sector context
#81 of 82
Health Care
What the data says
Among 82 Health Care companies, Harmony Biosciences Holdings, Inc. is in the top 1% for net debt per share. Net Debt per Share has declined for 4 consecutive years, from $-0.78 in FY2021 to $-10.30 in FY2025.
Based on SEC 10-K filings.
-10.30 in FY2025.
Improved from $-1.98 to $-10.30 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 82This company -$10.30 Sector average $1.13
▼
-1011.7% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s net debt per share has declined for 4 consecutive years.
- In FY2025, net debt per share decreased 113.7% year-over-year.
- Ranks #81 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2019.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.30 | -113.7% |
| FY2024 | -$4.82 | -143.4% |
| FY2023 | -$1.98 | -123.5% |
| FY2022 | -$0.89 | -13.8% |
| FY2021 | -$0.78 | +82.4% |
| FY2020 | -$4.41 | -146.7% |
| FY2019 | $9.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026